• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LUMINEX CORPORATION ARIES SARS-COV-2 ASSAY (24 CASSETTES) - IVD; ARIES SARS-COV-2 EUA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LUMINEX CORPORATION ARIES SARS-COV-2 ASSAY (24 CASSETTES) - IVD; ARIES SARS-COV-2 EUA Back to Search Results
Catalog Number 50-10047
Device Problem No Apparent Adverse Event (3189)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/08/2022
Event Type  malfunction  
Manufacturer Narrative
In light of the covid-19 pandemic and the subsequent authorizations (euas) for sars-cov-2 diagnostics tests and per the conditions of the emergency use authorization, suspected false negatives, false positives and significant deviations in expected performance characteristics will be reported under 21 cfr 803.The alleged false test results in this event have not caused patient injury or death; however, this event is being reported conservatively because if the alleged malfunction were to recur there is a non-remote potential for serious injury or death.
 
Event Description
Event description: customer reported two instances of false positive results for aries sars-cov2-eua had occurred while running a 3rd party negative control sample.Data review: on (b)(6) 2022, customer mayo foundation for medical education and research contacted luminex technical support to report two instances of false positive results for aries sars-cov2-eua assay pn: 50-10047 lot: ab5339a had occurred while running a 3rd party negative control sample.Customer provided run files show confirmation of unexpected results for 2 of the 2 negative quality control assay runs yielding positive sars-cov-2 results.Qc sample id sars-cov2 negative control natsars (cov2)-neg run name m12v120157001_3817792-12_20220225_084816 cassette id: 1cvcab5339221020a02966.Result: sars-cov-2 positive, orf1ab gene not detected, n-gene detected at ct 38.1, rnase p detected at ct 28.6.Qc sample id sars-cov2 negative control natsars (cov2)-neg run name m12v120157001_3818052-12_20220225_084815 cassette id: 1cvcab5339221020a02855.Result: sars-cov-2 positive, orf1ab gene not detected, n-gene detected at ct 37.5, rnase p detected at ct 29.3.Consumable review: no false results were reported during aql testing of lot: ab5339a on (b)(6) 2022.There is one ncmr associated with this lot for a documentation error.There are four additional complaint cases for lot: ab5339a all reported by this same customer within salesforce at this time.Device review: aries system sn: (b)(4), module sn: (b)(4).Review of the utilized device's history was accessed for a period of 6 months prior to the reported discrepant result.There were no service actions for the aries system nor module during the prior 6 months that would contribute to false results.Sample work-up: confirmation that the sample work-up was performed consistent with the package insert instruction was provided by the customer.Sample being tested was a 3rd party qc sample.No patient samples were reported to have false results.Conclusion: the root cause of the false positive results cannot be determined.There are no ncmr's associated with the lot utilized.There is no indication of consumable or hardware malfunction.Escalation case: (b)(4) previously investigated the occurrence of false positive results.It was determined that while a false positive result is possible, the limitations section of aries sars-cov-2 package insert, 89-30000-00-865, establishes that 'the results of this test should not be used as the sole basis for diagnosis, treatment, or other patient management decisions.' the risk was assessed on ra-lmnx-20-0161 and determined to be low risk.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARIES SARS-COV-2 ASSAY (24 CASSETTES) - IVD
Type of Device
ARIES SARS-COV-2 EUA
Manufacturer (Section D)
LUMINEX CORPORATION
12212 technology blvd
austin TX 78727
Manufacturer Contact
jordan smith
1224 deming way
madison, WI 53717
MDR Report Key16279762
MDR Text Key309288110
Report Number1650733-2023-00001
Device Sequence Number1
Product Code QJR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA200127
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 02/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/01/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Expiration Date10/20/2022
Device Catalogue Number50-10047
Device Lot NumberAB5339A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/04/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/19/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-